Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Dorn

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Urology|September 26, 2006
Limitations of radioguided surgery in high-risk prostate cancerDorothea Weckermann, Robert Dorn, Gabriele Holl, et al.
BJU International|April 18, 2007
Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancerDorothea Weckermann, Gabriele Holl, Robert Dorn, et al.
BJU International|May 12, 2006
Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomyDorothea Weckermann, Marcus Goppelt, Robert Dorn, et al.
The Journal of Urology|February 14, 2007
Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patientsDorothea Weckermann, Robert Dorn, M Trefz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approachRobert Dorn, Juergen Kopp, Harry Vogt, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S ProteasomeMarion G Götz, Kacey Godwin, Rachel Price, et al.
ACS Pharmacology & Translational Science|April 16, 2026
l‑Boronophenylalanine (l-BPA) Dipeptide Prodrugs Enhance Boron Delivery to Tumors, Facilitate Tumor Eradication and Induce Tumor Vaccine Effect in Mice Following Neutron IrradiationMichael Torgov, Arthur Raitano, Jason Cole Quintana, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Urology|September 26, 2006
Limitations of radioguided surgery in high-risk prostate cancerDorothea Weckermann, Robert Dorn, Gabriele Holl, et al.
BJU International|April 18, 2007
Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancerDorothea Weckermann, Gabriele Holl, Robert Dorn, et al.
BJU International|May 12, 2006
Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomyDorothea Weckermann, Marcus Goppelt, Robert Dorn, et al.
The Journal of Urology|February 14, 2007
Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patientsDorothea Weckermann, Robert Dorn, M Trefz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approachRobert Dorn, Juergen Kopp, Harry Vogt, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Macrocyclic Oxindole Peptide Epoxyketones-A Comparative Study of Macrocyclic Inhibitors of the 20S ProteasomeMarion G Götz, Kacey Godwin, Rachel Price, et al.
ACS Pharmacology & Translational Science|April 16, 2026
l‑Boronophenylalanine (l-BPA) Dipeptide Prodrugs Enhance Boron Delivery to Tumors, Facilitate Tumor Eradication and Induce Tumor Vaccine Effect in Mice Following Neutron IrradiationMichael Torgov, Arthur Raitano, Jason Cole Quintana, et al.
Pageof 1